Myeloma Today Fall 2012 Volume 9 Issue 3

Dear Reader

  • ​A Message from the President

Special Event

  • Professor Jesús San-Miguel is recipient of the Tenth Robert A. Kyle Lifetime Achievement Award

Scientific & Clinical

  • "Update on New Drugs- Kyprolis™ (carfilzomib)" by Dr. Thomas G. Martin
  •  "Update on New Drugs - Panobinostat" by Dr.Sagar Lonial
  •  "Update on New Drugs - Pomalidomide" - by Dr. Martha Lacy
  •  IMF Hotline Coordinators Answer Your Questions - "What You Need to Know About KYPROLIS™"

Nurse Leadership Board

  • Report from the 8th IMF Nurse Leadership Board (NLB) Meeting

Education and Awareness

  • Spotlight on Advocacy
  • Coalition for Cancer Drug Coverage Parity Converges in Washington, DC
  • The Supreme Court Upholds the Affordable Care Act
  • The IMF Advocacy Voice: Get Fired Up! Raise Your Voice! Get Out There and Take Action!
  • How to contact the IMF Advocacy Team

Support Groups

 2012 IMF Support Group Leaders’ Summit

International Affiliates

  • Updates from Around the Globe 
  •  IMF attends patient and doctor meetings in Japan: July 6-8, 2012

News & Notes

  • New Design, New Materials: IMF publications now have a fresh new look.
  • Don't Miss Out! Make your reservations for 2013 IMF Patient & Family Seminars now.
  • New Myeloma Trials Open for Enrollment
  • 50 Cancers Approved for Coverage by 9/11 Health Fund
  • The IMF on Facebook and Twitter
  • Help the IMF learn more about MM patients
  • Share Your Thoughts

IMF Staff Updates

  • Lisa Paik has been promoted to Senior VP of Clinical Education & Research Initiatives
  • Arin Assero has been promoted to VP of Global Advocacy
  • Meghan Buzby has been promoted to Director of US Advocacy
  • Zina Cary is our new National State Affairs Consultant

Member Events

  • 4th annual "IT" Fashion Show
  • Be Bold Be Bald
  • Coach Rob’s 7th Annual Benefit
  • Vehicle Donation

2012/2013 IMF Calendar of Events
Letters to the IMF

Click here to download Myeloma Today

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.